Brian Lacy
Gastroenterology · Lebanon, NHNPI 1518980135
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $141,870 of the $176,624 with a category attached, or 80.3%. It is spread thinly across 14 manufacturers, the largest accounting for just 22.6%. Among gastroenterology clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 64 payments — averaging $2759.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma Inc$40K
- Sanofi-aventis U.S. LLC$28K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$26K
- Ironwood Pharmaceuticals, Inc$19K
- Ardelyx, Inc.$16K
- Eli Lilly$11K
- plus $36K from 8 others
Across 20 payments — averaging $22,406 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ironwood Pharmaceuticals, Inc$290K
- Bausch Health US, LLC$104K
- AbbVie$25K
- Takeda Pharmaceuticals U.S.A., Inc.$23K
- Vanda Pharmaceuticals Inc.$6K
What the payments were for
- Consulting fees$141,87080%
- Speaking & faculty fees$8000%
- Travel & lodging$29,45017%
- Food & beverage$1,5041%
- Education$3,0002%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma Inc | 11 | $39,956 |
| Sanofi-aventis U.S. LLC | 4 | $28,249 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 19 | $25,593 |
| Ironwood Pharmaceuticals, Inc | 7 | $19,106 |
| Ardelyx, Inc. | 8 | $16,417 |
| Eli Lilly | 4 | $11,475 |
| GSK | 3 | $11,200 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $11,025 |
| Ferring Pharmaceuticals AS | 1 | $7,350 |
| AbbVie | 1 | $4,200 |
| Mylan Inc. | 1 | $1,857 |
| Boston Scientific | 1 | $103 |
| Stryker | 1 | $76 |
| Medtronic | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$176,624 in reported general payments places this provider in the 95th percentile of 91 gastroenterology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Esomeprazole Magnesium | 14 | $636 |
| Ondansetron OdtOndansetron | 13 | $359 |
| Mirtazapine | 16 | $211 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Lebanon
- Lee KaplanLebanon$1.2M
- Corey SiegelLebanon$602K
- Shelby SullivanLebanon$137K
- Michael WinterLebanon$58K
- Stuart GordonLebanon$42K
- Timothy GardnerLebanon$17K
- Liam ZakkoLebanon$5K
- Michael CurleyLebanon$4K
- Nicholas HannonLebanon$3K
- Leon McLeanDerry$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.